Prevalence study of genetically defined skeletal muscle channelopathies in England

Neurology

Volumn 80, Issue 16, 2013, Pages 1472-1475

  Horga, Alejandro ^a   Rayan, Dipa L Raja ^a   Matthews, Emma ^a   Sud, Richa ^a   Fialho, Doreen ^a   Durran, Siobhan C M ^a   Burge, James A ^a   Portaro, Simona ^a,b   Davis, Mary B ^a   Haworth, Andrea ^a   Hanna, Michael G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; SODIUM CHANNEL NAV1.4; UNCLASSIFIED DRUG; VOLTAGE GATED CHLORIDE CHANNEL; VOLTAGE GATED CHLORIDE CHANNEL 1; CHLORIDE CHANNEL; CLC 1 CHANNEL; CLC-1 CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ2 PROTEIN, HUMAN; SCN4A PROTEIN, HUMAN; SODIUM CHANNEL;

ADULT; ANDERSEN SYNDROME; ARTICLE; CLINICAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; MUSCLE CHANNELOPATHY; MYOTONIA; NONDYSTROPHIC MYOTONIA; PERIODIC PARALYSIS; PREVALENCE; PRIORITY JOURNAL; THOMSEN DISEASE; UNITED KINGDOM; CHANNELOPATHY; GENETIC DATABASE; GENETICS; HYPOKALEMIC PERIODIC PARALYSIS; MIDDLE AGED; MUSCLE DISEASE; MUTATION; PHYSIOLOGY; SKELETAL MUSCLE; STATISTICAL ANALYSIS;

ADULT; CHANNELOPATHIES; CHLORIDE CHANNELS; DATA INTERPRETATION, STATISTICAL; DATABASES, GENETIC; ENGLAND; FEMALE; GREAT BRITAIN; HUMANS; HYPOKALEMIC PERIODIC PARALYSIS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUTATION; MYOTONIA; MYOTONIC DISORDERS; NAV1.4 VOLTAGE-GATED SODIUM CHANNEL; PARALYSES, FAMILIAL PERIODIC; PARALYSIS, HYPERKALEMIC PERIODIC; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PREVALENCE; SODIUM CHANNELS;

EID: 85047688777     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31828cf8d0     Document Type: Article

References (10)

1. Meyer-Kleine C, Otto M, Zoll B, Koch MC. Molecular and genetic characterisation of German families with paramyotonia congenita and demonstration of founder effect in the Ravensberg families. Hum Genet 1994;93:707-710.
2. Baumann P, Myllyla VV, Leisti J. Myotonia congenita in northern Finland: an epidemiological and genetic study. J Med Genet 1998;35:293-296.
3. Papponen H, Toppinen T, Baumann P, et al. Founder mutations and the high prevalence of myotonia congenita in northern Finland. Neurology 1999;53:297-302.
4. Sun C, Tranebjaerg L, Torbergsen T, Holmgren G, Van Ghelue M. Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia. Eur J Hum Genet 2001;9:903-909.
5. Feero WG, Wang J, Barany F, et al. Hyperkalemic periodic paralysis: rapid molecular diagnosis and relationship of genotype to phenotype in 12 families. Neurology 1993;43:668-673.
6. Fouad G, Dalakas M, Servidei S, et al. Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul Disord 1997;7:33-38.
7. Miller TM, Dias Da Silva MR, Miller HA, et al. Correlating phenotype and genotype in the periodic paralyses. Neurology 2004;63:1647-1655.
8. Donaldson MR, Yoon G, Fu YH, Ptacek LJ. Andersen-Tawil syndrome: a model of clinical variability, pleiotropy, and genetic heterogeneity. Ann Med 2004;36(suppl 1):92-97.
9. Lossin C, George AL Jr. Myotonia congenita. Adv Genet 2008;63:25-55.
10. Vicart S, Sternberg D, Fontaine B, Meola G. Human skeletal muscle sodium channelopathies. Neurol Sci 2005;26:194-202.